A Commotion in the Skin: Developing Melanoma Immunotherapies-Reference-Cited by-同舟云学术

A Commotion in the Skin: Developing Melanoma Immunotherapies

Published:2022-08 Issue:8 Volume:142 Page:2055-2060
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Brenner Ellen^ORCID,Röcken Martin^ORCID

Funder

Deutsche Krebshilfe

Wilhelm Sander-Stiftung

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference56 articles.

1. Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence;Ahmetlic;J Immunother Cancer,2021

2. Signatures of mutational processes in human cancer [published correction appears in Nature 2013;502:258];Alexandrov;Nature,2013

3. Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma;Ascierto;Nat Med,2019

5. Restoring function in exhausted CD8 T cells during chronic viral infection;Barber;Nature,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of PD-L1 by Astragalus polysaccharide attenuates the induction of melanoma stem cell properties and overcomes immune evasion;BMC Cancer;2024-08-21

2. Prognostic and immune infiltration implications of SIGLEC9 in SKCM;Diagnostic Pathology;2024-08-17

3. The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma;Pigment Cell & Melanoma Research;2024-08-08

4. KIF4A functions as a diagnostic and prognostic biomarker and regulates tumor immune microenvironment in skin cutaneous melanoma;Pathology - Research and Practice;2024-02

5. Identification of a cuproptosis-associated gene signature and Peptidylprolyl isomerase C as therapeutic target in cutaneous melanoma;2023-08-05